drugset / Trial / NCT00612560

Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics

NCT00612560

RandomizedFactorialQuadruple-blindBasic science

Summary

The proposed study plans to examine the effect of flaxseed consumption, a phytoestrogen rich food, compared to aromatase inhibitors as a complementary approach to treating estrogen receptor positive breast cancer, as well as the effect of combined flaxseed and aromatase inhibitor therapy on breast cancer treatment. Because of the increasing use of both complementary and alternative approaches to treatment, and the use of aromatase inhibitors in the treatment of breast cancer, the proposed study has potential to provide important clinical information about the effect of foods high in phytoestrogens on a common endocrine therapy used in breast cancer.

Timeline

Start
2007-11
Primary completion
2011-01
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified 1 mg

Indications